{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:31:59Z","timestamp":1793417519327,"version":"4.5.0"},"reference-count":70,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Health of the Republic of Kazakhstan","award":["BR25293294"],"award-info":[{"award-number":["BR25293294"]}]},{"award":["BR25293294"],"award-info":[{"award-number":["BR25293294"]}],"id":[{"id":"https:\/\/ror.org\/022syee28","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Brucellosis remains one of the most widespread zoonotic infections worldwide, causing serious veterinary, medical, and socio-economic consequences. The disease, caused by bacteria of the genus Brucella, affects a wide range of domestic and wild animals as well as humans, with global incidence potentially reaching 1.6\u20132.1 million new cases annually. The most effective approach to combating brucellosis is specific prevention through vaccination. Therefore, we conducted this review to summarize data from existing studies on modern strategies for brucellosis vaccination, types of vaccine platforms, their efficacy, safety, and applicability in veterinary and human medicine. We searched databases including PubMed, Scopus, and Web of Science to identify relevant scientific articles in English published from 1990 to 2025. The aim of this work is to conduct a systematic analysis of modern brucellosis vaccination strategies in livestock and humans, as well as to evaluate the prospects of new vaccine platforms. The review examines live attenuated, inactivated, subunit, vector, and DNA vaccines, as well as their immunological mechanisms of action, advantages, and limitations of application. This information allows for a better understanding of the mechanisms of protective immunity formation and challenges related to DIVA diagnostics (Differentiating Infected from Vaccinated Animals). The \u201cOne Health\u201d concept demonstrated the interconnection between human, animal, and environmental factors, emphasizing the need for an interdisciplinary approach to brucellosis monitoring, prevention, and control. Vector vaccines based on influenza virus (Flu-BA), developed in Kazakhstan, have shown high promise, combining immunogenicity, protective efficacy, and a favorable safety profile. Promising directions remain mRNA vaccines, nanoparticles, CRISPR\/Cas9 technologies, and mucosal vaccines.<\/jats:p>","DOI":"10.3390\/vaccines14050409","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:15:27Z","timestamp":1777630527000},"page":"409","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Modern Strategies for Brucellosis Vaccination: From Traditional Approaches to Innovative Platforms"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7267-3931","authenticated-orcid":false,"given":"Nurika","family":"Assanzhanova","sequence":"first","affiliation":[{"name":"Research Institute for Biological Safety Problems, National Holding \u201cQazBioPharm\u201d, Gvardeiskiy 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4238-5116","authenticated-orcid":false,"given":"Kuandyk","family":"Zhugunissov","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, National Holding \u201cQazBioPharm\u201d, Gvardeiskiy 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7954-6246","authenticated-orcid":false,"given":"Olga","family":"Chervyakova","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, National Holding \u201cQazBioPharm\u201d, Gvardeiskiy 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sholpan","family":"Ryskeldinova","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, National Holding \u201cQazBioPharm\u201d, Gvardeiskiy 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8896-3482","authenticated-orcid":false,"given":"Nurlan","family":"Akmyrzayev","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, National Holding \u201cQazBioPharm\u201d, Gvardeiskiy 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5938-3454","authenticated-orcid":false,"given":"Aigerim","family":"Sagymbayeva","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, National Holding \u201cQazBioPharm\u201d, Gvardeiskiy 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0627-0442","authenticated-orcid":false,"given":"Yeldos","family":"Myrzakhmetov","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, National Holding \u201cQazBioPharm\u201d, Gvardeiskiy 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4722-0495","authenticated-orcid":false,"given":"Aigerim","family":"Mailybayeva","sequence":"additional","affiliation":[{"name":"Research Institute for Biological Safety Problems, National Holding \u201cQazBioPharm\u201d, Gvardeiskiy 080409, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Wang, W., Lu, S., Li, S., Ree, M.J., and Cui, W. (2020). A man with recurrent fever, arthritis, and rash\u2014Brucellosis? A case report. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-019-4746-0"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Elbehery, A., Aldubaib, M., Al Rugaie, O., Marzouk, E., Abaalhail, M., Moussa, I., El-Husseiny, M.H., Abaalhail, A., and Rawway, M. (2022). Proteomic screening and antibiotic resistance assessment of clinical and subclinical Brucella species: Evolution of Brucellosis infection control. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0262551"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Elbehery, A., Aldubaib, M., Al Rugaie, O., Marzouk, E., Moussa, I., El-Husseiny, M., Ibrahim, M., Abalhail, A., and Rawway, M. (2022). Brucella species-induced brucellosis: Antimicrobial effects, potential resistance, and toxicity of silver and gold nanoparticles. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0269963"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.3201\/eid2909.230052","article-title":"Global Estimate of Human Brucellosis Incidence","volume":"29","author":"Laine","year":"2023","journal-title":"Emerg. Infect. Dis."},{"key":"ref_5","unstructured":"Centers for Disease Control and Prevention (2026, April 28). CDC Estimates Human Brucella Infections Could be Four Times Higher Than Previously Thought, Food Safety, Available online: https:\/\/www.food-safety.com\/articles\/8817-cdc-estimates-human-brucella-infections-could-be-four-times-higher-than-previously-thought?__cf_chl_tk=rVCl61.7qCvs.mhsRA61TxttxTESn0oFmX1jddb8NhY-1777607942-1.0.1.1-6Wilr1cXIKy.5WFKgAgE.KrLC.W_0aYnEw_SS5QqnHQ."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5897\/JVMAH2017.0639","article-title":"Review of common causes of abortion in dairy cattle in Ethiopia","volume":"10","author":"Dereje","year":"2018","journal-title":"J. Vet. Med. Anim. Health"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.51585\/gjvr.2021.0006","article-title":"Seroprevalence and molecular diagnosis of sheep Brucellosis in Dakahlia province, Egypt","volume":"1","author":"Abdelhalek","year":"2021","journal-title":"Ger. J. Vet. Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Dione, M.M., S\u00e9ry, A., Sidib\u00e9, C.A.K., Wieland, B., and Fall, A. (2022). Exposure to multiple pathogens\u2014Serological evidence of Rift Valley fever virus, Coxiella burnetii, bluetongue virus, and Brucella spp. in cattle, sheep, and goats in Mali. PLoS Negl. Trop. Dis., 16.","DOI":"10.1371\/journal.pntd.0010342"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijfoodmicro.2018.12.009","article-title":"Human Brucellosis caused by raw dairy products: A review of prevalence, major risk factors, and prevention","volume":"292","author":"Dadar","year":"2018","journal-title":"Int. J. Food Microbiol."},{"key":"ref_10","first-page":"114","article-title":"Study of Brucellosis in a pastoral community and evaluation of the usefulness of clinical signs and symptoms in differentiating it from other flu-like diseases","volume":"7","author":"Maichomo","year":"2007","journal-title":"Afr. J. Health Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.trstmh.2007.05.016","article-title":"Persistence and relapse in Brucellosis and need for improved treatment","volume":"101","author":"Franco","year":"2007","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Rossetti, C.A., Arenas-Gamboa, A.M., and Maurizio, E. (2017). Caprine Brucellosis: A historically neglected disease with significant impact on public health. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005692"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s15010-021-01586-w","article-title":"Current therapeutic strategies in human Brucellosis","volume":"49","author":"Bosilkovski","year":"2021","journal-title":"Infection"},{"key":"ref_14","unstructured":"Barakat, A. (2026, April 10). Brucellosis, Medscape, Available online: https:\/\/emedicine.medscape.com\/article\/213430-overview."},{"key":"ref_15","unstructured":"World Health Organization (2026, April 28). Brucellosis, WHO Fact Sheets, Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/brucellosis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/01652176.2020.1868616","article-title":"Bovine brucellosis\u2014A comprehensive review","volume":"41","author":"Khurana","year":"2021","journal-title":"Vet. Q."},{"key":"ref_17","first-page":"27","article-title":"Public health and economic importance of Bovine brucellosis: An overview","volume":"5","author":"Pal","year":"2017","journal-title":"Am. J. Epidemiol. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/zph.12582","article-title":"Economic and Medical Burden of Brucellosis in Kazakhstan","volume":"66","author":"Charypkhan","year":"2019","journal-title":"Zoonoses Public Health"},{"key":"ref_19","first-page":"29","article-title":"Monitoring of the Epizootic Situation of Brucellosis among Animals and Humans in Kostanay Region","volume":"3","author":"Kassymov","year":"2025","journal-title":"Nauka Obraz."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Shevtsova, E., Shevtsov, A., Mukanov, K., Filipenko, M., Kamalova, D., Sytnik, I., Syzdykov, M., Kuznetsov, A., Akhmetova, A., and Zharova, M. (2016). Epidemiology of Brucellosis and Genetic Diversity of Brucella abortus in Kazakhstan. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0167496"},{"key":"ref_21","unstructured":"Ivanov, N.P. (2007). Brucellosis in Animals and Control Measures, Atamura. (In Russian)."},{"key":"ref_22","first-page":"77","article-title":"Historical perspective of Brucellosis: A microbiological and epidemiological overview","volume":"24","author":"Akpinar","year":"2016","journal-title":"Infez. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.022622699","article-title":"Brucella melitensis: A nasty bug with hidden credentials for virulence","volume":"99","author":"Moreno","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","unstructured":"Mandell, G.L., Bennett, J.E., and Dolin, R. (2005). Brucella Species. Principles and Practice of Infectious Diseases, Churchill Livingstone. [6th ed.]."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0378-1135(02)00217-1","article-title":"Brucellosis in the European Union and Norway at the Turn of the Twenty-First Century","volume":"90","author":"Godfroid","year":"2002","journal-title":"Vet. Microbiol."},{"key":"ref_26","first-page":"197","article-title":"Interactions between professional phagocytes and Brucella spp.","volume":"12","author":"Liautard","year":"1996","journal-title":"Microbiology"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Barquero-Calvo, E., Chaves-Olarte, E., Weiss, D.S., Guzman-Verri, C., Chacon-Diaz, C., Rucavado, A., Moriy\u00f3n, I., and Moreno, E. (2007). Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0000631"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1600-065X.2010.00982.x","article-title":"An evolutionary strategy for a stealthy intracellular Brucella pathogen","volume":"240","author":"Martirosyan","year":"2011","journal-title":"Immunol. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0378-1135(02)00248-1","article-title":"Incidence and control of Brucellosis in the Near East region","volume":"90","author":"Refai","year":"2002","journal-title":"Vet. Microbiol."},{"key":"ref_30","first-page":"8","article-title":"A review on bovine Brucellosis: Epidemiology, diagnosis, and Control Options","volume":"2","author":"Kiros","year":"2016","journal-title":"ARC J. Anim. Vet. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.molimm.2015.04.004","article-title":"A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy","volume":"66","author":"Li","year":"2015","journal-title":"Mol. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.actatropica.2015.10.023","article-title":"Brucellosis in Sub-Saharan Africa: Current challenges for management, diagnosis and control","volume":"165","author":"Ducrotoy","year":"2017","journal-title":"Acta Trop."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1016\/j.vaccine.2019.05.084","article-title":"The advances in Brucellosis vaccines","volume":"37","author":"Hou","year":"2019","journal-title":"Vaccine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13567-015-0199-7","article-title":"Recent Advances in Brucella abortus Vaccines","volume":"46","author":"Dorneles","year":"2015","journal-title":"Vet. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/CMR.16.1.65-78.2003","article-title":"Molecular host-pathogen interaction in Brucellosis: Current understanding and future approaches to vaccine development for mice and humans","volume":"16","author":"Ko","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4142\/jvs.2017.18.S1.281","article-title":"Development and trial of vaccines against Brucella","volume":"18","author":"Lalsiamthara","year":"2017","journal-title":"J. Vet. Sci."},{"key":"ref_37","first-page":"68","article-title":"Protective efficacy of an inactivated Brucella abortus vaccine candidate lysed by GI24 against Brucellosis in Korean black goats","volume":"83","author":"Kim","year":"2019","journal-title":"Can. J. Vet. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0378-1135(91)90108-R","article-title":"The effects of adjuvants on immune responses in cattle injected with a Brucella abortus soluble antigen","volume":"29","author":"Dzata","year":"1991","journal-title":"Vet. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0165-2427(93)90198-D","article-title":"Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams","volume":"37","author":"Blasco","year":"1993","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.2460\/ajvr.1992.53.10.1900","article-title":"Monophosphoryl lipid A-induced immune enhancement of Brucella abortus salt-extractable protein and lipopolysaccharide vaccines in BALB\/c mice","volume":"53","author":"Tabatabai","year":"1992","journal-title":"Am. J. Vet. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.4314\/tjpr.v15i10.4","article-title":"Induction of protective immune responses in mice by double DNA vaccine encoding of Brucella melitensis Omp31 and Escherichia coli Eae genes","volume":"15","author":"Ranjbar","year":"2016","journal-title":"Trop. J. Pharm. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2217\/fmb.12.140","article-title":"Brucella Evasion of Adaptive Immunity","volume":"8","author":"Martirosyan","year":"2013","journal-title":"Future Microbiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1586\/erv.10.57","article-title":"DNA vaccines for targeting bacterial infections","volume":"9","author":"Ingolotti","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1128\/IAI.70.4.1915-1923.2002","article-title":"Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen","volume":"70","author":"Tibor","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1016\/j.vaccine.2011.04.088","article-title":"Co-immunization with interleukin-18 enhances the protective efficacy of liposomes encapsulated recombinant Cu\u2013Zn superoxide dismutase protein against Brucella abortus","volume":"29","author":"Singha","year":"2011","journal-title":"Vaccine"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1574-6976.2010.00211.x","article-title":"Towards a Brucella vaccine for humans","volume":"34","author":"Perkins","year":"2010","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"D40","DOI":"10.1016\/j.vaccine.2009.08.058","article-title":"Brucellosis: The case for live, attenuated vaccines","volume":"27","author":"Ficht","year":"2009","journal-title":"Vaccine"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1080\/14760584.2016.1208089","article-title":"Influenza viral vector-based Brucella abortus vaccine: A novel vaccine candidate for veterinary practice","volume":"15","author":"Tabynov","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Ryskeldinova, S., Zinina, N., Kydyrbayev, Z., Yespembetov, B., Kozhamkulov, Y., Inkarbekov, D., Assanzhanova, N., Mailybayeva, A., Bugybayeva, D., and Sarmykova, M. (2021). Registered Influenza Viral Vector-Based Brucella abortus Vaccine for Cattle in Kazakhstan: Age-wise safety and Efficacy Studies. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.669196"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-11-69","article-title":"Influenza viral vectors expressing the Brucella Omp16 or L7\/L12 proteins as vaccines against B. abortus infection","volume":"11","author":"Tabynov","year":"2014","journal-title":"Virol. J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.vaccine.2014.02.058","article-title":"Novel influenza virus vectors expressing Brucella L7\/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection","volume":"32","author":"Tabynov","year":"2014","journal-title":"Vaccine"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.vaccine.2015.12.028","article-title":"Prime-booster vaccination of cattle with an influenza viral vector Brucella abortus vaccine induces a long-term protective immune response against Brucella abortus infection","volume":"34","author":"Tabynov","year":"2016","journal-title":"Vaccine"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Mailybayeva, A., Yespembetov, B., Ryskeldinova, S., Zinina, N., Sansyzbay, A., Renukaradhya, G.J., and Tabynov, K. (2017). Improved influenza viral vector-based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0186484"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1438928","DOI":"10.1155\/2020\/1438928","article-title":"Development of human vectored Brucellosis Vaccine Formulation: Assessment of Safety and Protectiveness of Influenza Viral Vectors Expressing Brucella Immunodominant Proteins in Mice and Guinea Pigs","volume":"2020","author":"Bugybayeva","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40249-021-00801-y","article-title":"A new candidate vaccine for human Brucellosis based on influenza viral vectors: A preliminary investigation for the development of an immunization schedule in a guinea pig model","volume":"10","author":"Bugybayeva","year":"2021","journal-title":"Infect. Dis. Poverty"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7774\/cevr.2024.13.3.232","article-title":"Intranasal and intraperitoneal immunization against Brucella infection using niosome and mannosylated niosomes containing Brucella recombinant trigger factor\/Bp26\/Omp31 chimeric protein in a mouse model","volume":"13","author":"Sharif","year":"2024","journal-title":"Clin. Exp. Vaccine Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e01079","DOI":"10.1016\/j.heliyon.2018.e01079","article-title":"Development of new generation of vaccines for Brucella abortus","volume":"4","author":"Gheibi","year":"2018","journal-title":"Heliyon"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/dna.2008.0790","article-title":"A combined DNA vaccine provides protective immunity against Mycobacterium bovis and Brucella abortus in cattle","volume":"28","author":"Hu","year":"2009","journal-title":"DNA Cell Biol."},{"key":"ref_59","first-page":"1302","article-title":"Evaluation of a DNA vaccine encoding Brucella BvrR in BALB\/c mice","volume":"19","author":"Chen","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_60","first-page":"957","article-title":"Immunogenicity evaluation of plasmids encoding Brucella melitensis Omp25 and Omp31 antigens in BALB\/c mice","volume":"21","author":"Shojaei","year":"2018","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.micpath.2018.10.016","article-title":"Evaluation of DNA vaccine encoding BCSP31 surface protein of Brucella abortus for protective immunity","volume":"125","author":"Imtiaz","year":"2018","journal-title":"Microb. Pathog."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3855\/jidc.2296","article-title":"Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis","volume":"7","author":"Abbady","year":"2013","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1016\/j.vaccine.2014.06.012","article-title":"Evaluation of immunogenicity and protective efficacy of a plasmid DNA vaccine encoding ribosomal protein L9 of Brucella abortus in BALB\/c mice","volume":"32","author":"Jain","year":"2014","journal-title":"Vaccine"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Darbandi, A., Alamdari, S.Z., Kupai, M., Ganavati, R., Heidari, M., and Talebi, M. (2022). Evaluation of immune responses to Brucella vaccines in mouse models: A systematic review. Front. Vet. Sci., 9.","DOI":"10.3389\/fvets.2022.903890"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"5524768","DOI":"10.1155\/2024\/5524768","article-title":"Efficacy of Brucella vaccines in sheep: A systematic review and meta-analysis","volume":"2024","author":"Li","year":"2024","journal-title":"Transbound. Emerg. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11515-012-1196-0","article-title":"Progress in Brucella vaccine development","volume":"8","author":"Yang","year":"2013","journal-title":"Front. Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e03383-23","DOI":"10.1128\/spectrum.03383-23","article-title":"A genome-wide CRISPR screen identified host genes essential for intracellular Brucella survival","volume":"12","author":"Xu","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"30698","DOI":"10.1038\/s41598-025-09509-7","article-title":"Design of a multi-epitope mRNA vaccine against the Brucella type IV secretion system using reverse vaccinology and immunogenicity approaches","volume":"15","author":"Luo","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.2147\/IJN.S249942","article-title":"Nanoparticle-based vaccines for Brucellosis: Calcium phosphate nanoparticles-adsorbed antigens induce cross-protective response in mice","volume":"15","author":"Sadeghi","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.coi.2011.03.006","article-title":"Viral Vectors as Vaccine Platforms: Deployment in Sight","volume":"23","author":"Rollier","year":"2011","journal-title":"Curr. Opin. Immunol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/5\/409\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:23:21Z","timestamp":1777631001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/5\/409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":70,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["vaccines14050409"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14050409","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}